Krista Lane Lausen, PT | |
509 Fort St Ste B, Buffalo, WY 82834-1867 | |
(307) 684-8623 | |
(307) 684-8623 |
Full Name | Krista Lane Lausen |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 28 Years |
Location | 509 Fort St Ste B, Buffalo, Wyoming |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649597642 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT-0676 (Wyoming) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sherwood Group Inc | 8426950767 | 12 |
News Archive
By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit newly minted viral particles.
Half of patients referred to a specialist centre with a diagnosis of chronic inflammatory demyelinating polyneuropathy do not actually have the condition, report researchers.
Low testosterone levels may be associated with a higher risk of falling in older men, according to a report in the October 23 issue of Archives of Internal Medicine.
Keryx Biopharmaceuticals, Inc. (the "Company") today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of KRX-0401 (Perifosine) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of Clinical Cancer Research.
› Verified 6 days ago
Provider Name | Sherwood Group Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1346255130 PECOS PAC ID: 8426950767 Enrollment ID: O20040126000655 |
News Archive
By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit newly minted viral particles.
Half of patients referred to a specialist centre with a diagnosis of chronic inflammatory demyelinating polyneuropathy do not actually have the condition, report researchers.
Low testosterone levels may be associated with a higher risk of falling in older men, according to a report in the October 23 issue of Archives of Internal Medicine.
Keryx Biopharmaceuticals, Inc. (the "Company") today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of KRX-0401 (Perifosine) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of Clinical Cancer Research.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Krista Lane Lausen, PT 164 W Hart St, Buffalo, WY 82834-1738 Ph: (307) 684-8623 | Krista Lane Lausen, PT 509 Fort St Ste B, Buffalo, WY 82834-1867 Ph: (307) 684-8623 |
News Archive
By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit newly minted viral particles.
Half of patients referred to a specialist centre with a diagnosis of chronic inflammatory demyelinating polyneuropathy do not actually have the condition, report researchers.
Low testosterone levels may be associated with a higher risk of falling in older men, according to a report in the October 23 issue of Archives of Internal Medicine.
Keryx Biopharmaceuticals, Inc. (the "Company") today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of KRX-0401 (Perifosine) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of Clinical Cancer Research.
› Verified 6 days ago
Brittany Leafe, Physical Therapist Medicare: Medicare Enrolled Practice Location: 93 Bighorn Dr, Buffalo, WY 82834 Phone: 307-217-3781 | |
Marye Carlson, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 497 W Lott St, Buffalo, WY 82834 Phone: 307-684-6172 | |
Remount Physical Therapy, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 93 Bighorn Dr, Buffalo, WY 82834 Phone: 307-217-3781 | |
Mrs. Cathy Monique Miner, M.S.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 164 W Hart St, Buffalo, WY 82834 Phone: 307-684-8623 | |
Buffalo Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 509 Fort St Ste B, Buffalo, WY 82834 Phone: 307-684-8623 Fax: 307-684-8623 | |
Joel Killian, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 N Desmet Ave, Buffalo, WY 82834 Phone: 307-684-9271 |